参考文献/References:
[1] 全国细菌耐药监测网 .全国细菌耐药监测网 2014~ 2019年耐碳青霉烯类肺炎克雷伯菌流行病学变迁 [J].中国感染控制杂志 ,2021,20(2):175-179. China Antimicrobial Resistance Surveillance System. Epidemiological change in carbapenem-resistant Klebsiella pneumoniae:surveillance report from China Antimicrobial Resistance Surveillance in 2014~ 2019 [J]. Chinese Journal of Infection Control,2021,20(2):175-179.
[2] AGYEMAN A A, BERGEN P J, RAO G G, et al. A systematic review and meta-analysis of treatment outcomes following antibiotic therapy among patients with carbapenem-resistant Klebsiella pneumoniae infections[J]. International Journal of Antimicrobial Agents, 2020, 55(1): 105833.
[3] 徐卫皓 , 杨凤真 , 伊茂礼 , 等.临床耐碳青霉烯类肠杆菌科细菌对头孢他啶 /阿维巴坦的药物敏感性分析 [J].现代检验医学杂志 , 2022, 37(1):164-167. XU Weihao, YANG Fengzhen, YI Maoli , et al. Drug sensitivity analysis of clinical Carbapenem-resistant Enterobacteriaceae bacteria to Ceftazidime/ Avibatan [J]. Journal of Modern Laboratory Medicine, 2022,37(1):164-167.
[4] 程成 , 张薇 , 朱波 , 等 .中药抗常见耐药菌的作用及其机制研究进展 [J].南京中医药大学学报 , 2019, 35(2):229-233. CHENG Cheng, ZHANG Wei, ZHU Bo, et al. Effects and mechanisms of traditional chinese medicine on drug-resistant bacteria: research progress and future directions [J].Journal of Nanjing University of Traditional Chinese Medicine, 2019,35(2):229-233.
[5] 马冬梅 , 陶庆春 , 齐宏伟.痰热清联合亚胺培南或米诺环素对广泛耐药肺炎克雷伯菌的体外抑菌作用 [J].中国临床研究 , 2019, 32(4):549-551. MA Dongmei, TAO Qingchun, QI Hongwei. Inhibitory effect of Tanreqing combined with imipenem or minocycline on extensively drug-resistant Klebsiella pneumoniae in vitro [J]. Chinese Journal of Clinical Research,2019,32(4):549-551.
[6] 杜蕾 ,焦伟杰 ,张翔云等 .清金化痰汤联合亚胺培南体外抑菌活性研究 [J].中西医结合研究 , 2022, 14(2):93-96. DU Lei, JIAO Weijie, ZHANG Xiangyun, et al. In vitro antibacterial activity study of Qingjin Huatan decoction combined with imipenem for multidrug resistant Klebsiella pneumoniae [J]. Research of Integrated Traditional Chinese and Western Medicine, 2022, 14(2):93-96.
[7] Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing.Thirty informational supplement[S].Wayne: PA, CLSI M100-S30, 2020.
[8] XU Liangfei, SUN Xiaoxi, MA Xiaoling.Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae[J]. Annals of Clinical Microbiology and Antimicrobials, 2017, 16(1): 18.
[9] 杜芳玲 , 梅艳芳 , 魏丹丹 , 等.CRKP血流感染危险因素和耐药及毒力特征 [J].中华医院感染学杂志 , 2021, 31(22):3361-3365. DU Fangling, MEI Yanfang, WEI Dandan, et al. Risk factors for CRKP bloodstream infection, drug resistance and virulence characteristics [J]. Chinese Journal of No socomiology,2021,31(22):3361-3365.
[10] MIETHKE M, PIERONI M, WEBER T, et al. Towards the sustainable discovery and development of new antibiotics[J]. Nature Reviews Chemistry, 2021, 5(10): 726-749.
[11] 黄梅 , 谭余庆 , 罗俊 , 等 .植物类中药抗细菌耐药性的研究进展 [J].中国实验方剂学杂志 , 2018, 24 (23): 218-224. HUANG Mei, TAN Yuqing, LUO Jun, et al. Antimicro-bial resistance of chinese herbal medicine [J]. Chinese Journal of Experimental Traditional Medical Formulae, 2018, 24 (23):218-224.
[12] 翟贯星 ,陆璐 ,陈代杰 ,等 .中药化合物的抗菌及增效作用 [J].中国抗生素杂志 , 2019,44(12):1366-1370. ZHAI Guanxing, LU Lu, CHEN Daijie,et al. Antimicrobial and synergisicm effects of traditional Chinese medicine compounds [J]. Chinese Journal of Antibiotics,2019,44(12):1366-1370.
[13] 干铁儿 ,林少华 ,李文杰 ,等 .黄连素联合亚胺培南西司他丁对耐碳青霉烯类肺炎克雷伯菌的体外抑菌作用 [J].中华医院感染学杂志 , 2021, 31(21): 3211-3215. GAN Tie’er, LIN Shaohua, LI Wenjie, et al. In vitro antibacterial effect of berberine combined with imipenem-cilastatin on carbapenem-resistant Klebsiella pneumoniae [J]. Chinese Journal of Nosocomiology, 2021,31(21):3211-3215.
[14] 吴缠婷 , 周良良 , 邹婉清 , 等 .黄芩苷的药理特性及其作用机制研究进展 [J].中华中医药学刊 , 2022, 40(2):63-67. WU Chanting, ZHOU Liangliang, ZOU Wanqing, et al. Research progress on pharmacological properties and mechanism of Baicalin [J]. Chinese Archives of Traditional Chinese Medicine,2022,40(2):63-67.
[15] 陈朝彦 , 秦志丹 , 蒋良艳 , 等.双组分系统调控肺炎克雷伯菌碳青霉烯耐药机制的研究进展 [J].中华危重病急救医学 , 2021, 33(6):761-764. CHEN Chaoyan, QIN Zhidan, JIANG Liangyan, et al. Research progress on the mechanism of two-component systems in regulating carbapenem resistance of Klebsiella pneumonia [J]. Chinese Critical Care Medicine, 2021,33(6):761-764.
[16] 韩佳慧 , 刘唐娟 , 罗劲 , 等 .不同浓度黄芩苷对高毒力肺炎克雷伯菌生长及生物被膜形成能力影响的初步探讨 [J].临床肺科杂志 , 2022, 27(3):342-345. HAN Jiahui, LIU Tangjuan, LUO Jin, et al. A preliminary study on the effects of different concentrations of Baicalin on the growth and biofilm formation of hypervirulent Klebsiella pneumoniae [J]. Journal of Clinical Pulmonary Medicine,2022,27(3):342-345.
[17] SHI Cheng, BAO Jingxiao, SUN Ying, et al. Discovery of Baicalin as NDM-1 inhibitor: Virtual screening, biological evaluation and molecular simulation [J]. Bioorganic Chemistry, 2019, 88: 102953.
[18] 高元峰 , 王瑞颖 , 易柳 , 等.中国药典 2020年版 (一部 )收载毒性中药及其注意事项统计分析 [J].中国药师 , 2021, 24(6):1133-1137. GAO Yuanfeng, WANG Ruiying, YI Liu, et al. Statistical analysis of toxic herbs and points for attention in Chinese pharmacopoeia(2020 Edition,Part I)[J]. China Pharmacist,2021,24(6):1133-1137.